This inventor holds 1 USPTO granted patent. Top assignee: Mannkind Corporation. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: John L Simard: Innovator in Immunotherapy
Introduction
John L Simard is a notable inventor based in Northridge, CA (US). He has made significant contributions to the field of immunotherapy, particularly through his innovative methods for inducing cytotoxic T-lymphocyte (CTL) responses. His work is essential in advancing treatments for tumors and infectious diseases.
Latest Patents
John L Simard holds 1 patent for a method of inducing a CTL response. This patent describes a technique that involves delivering an antigen to the lymphatic system of an animal over a sustained period using an osmotic pump. This method is advantageous as it eliminates the need for repetitive immunizations or the use of adjuvants, making it a more efficient approach for immunotherapy.
Career Highlights
Simard is associated with Mannkind Corporation, where he applies his expertise in immunotherapy. His work at the company focuses on developing innovative solutions that enhance the effectiveness of treatments for various diseases.
Collaborations
One of his notable coworkers is Thomas M Kündig, with whom he collaborates on various projects related to immunotherapy and related fields.
Conclusion
John L Simard's contributions to immunotherapy through his patented methods demonstrate his commitment to advancing medical science. His innovative approach has the potential to significantly impact the treatment of tumors and infectious diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile